数据链接：
官方服务：
资源简介：
Regimens of cisplatin-based chemotherapy.
应用场景：
创建时间：
2019-04-25
相关数据集
Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis
Background: Positive results of randomized trials led to the introduction of FOLFIRINOX in 2012 and gemcitabine with nab-paclitaxel in 2015 for patients with metastatic pancreatic ductal adenocarcinom
Figshare2020-02-14 更新40
Scheduling Nab-paclitaxel With Gemcitabine
Metastatic pancreatic cancer is difficult to treat. Until recently, most patients would be offered treatment with a chemotherapy drug called gemcitabine. However, a large international trial showed th
NIAID Data Ecosystem30
Supplementary Table S4 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma
Supplementary Table S4. Chemotherapy Regimens.
Figshare2025-02-17 更新10
A multicenter phase III randomized trial comparing TAXOTERE administered either weekly or every three weeks in combination with prednisone versus mitoxantrone in combination with prednisone for metastatic hormone-refractory prostate cancer
Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promot
DataCite Commons2024-12-02 更新30
Features of included agents and studies.
N-S, non-squamous cell carcinoma; TC, paclitaxel+carboplatin; GP, gemcitabine+cisplatin; DOC, docetaxol; PEM, pemetrxed. Features of included agents and studies.
NIAID Data Ecosystem20
